Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions
Alyssa Duffy, Maryam I. Azeem, Smriti Kanangat, Melinda Yushak, David Lawson, Madhav V. Dhodapkar, Kavita M. Dhodapkar
Alyssa Duffy, Maryam I. Azeem, Smriti Kanangat, Melinda Yushak, David Lawson, Madhav V. Dhodapkar, Kavita M. Dhodapkar
View: Text | PDF
Research Letter Immunology Oncology

Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions

  • Text
  • PDF
Abstract

Authors

Alyssa Duffy, Maryam I. Azeem, Smriti Kanangat, Melinda Yushak, David Lawson, Madhav V. Dhodapkar, Kavita M. Dhodapkar

×

Figure 1

Mechanisms of T/B interactions.

Options: View larger image (or click on image) Download as PowerPoint
Mechanisms of T/B interactions.
(A–C) T/B cocultures. Purified B cells w...
(A–C) T/B cocultures. Purified B cells were cultured alone or with flow-sorted ICOS+CD4+ and ICOS–CD4+ T cells from patients with melanoma after CCB treatment (Supplemental Methods). (A) Representative flow plot of CD38+CD27+ plasmablast. (B) Human IgG levels by ELISA (n = 9). Kruskal-Wallis with Dunn’s multiple comparisons correction. (C) Effect of B cell subsets. Flow-sorted posttreatment T cells were cultured with memory(n = 5) or naive B cells (n = 6). Bar graphs indicate fold change compared with cultures with B cells alone. One-way ANOVA with Tukey’s multiple test correction. (D–F) Human T/B interactions in vivo. Sorted ICOS+CD4+ or ICOS–CD4+ T cells from patients with melanoma (n = 5) were injected into MISTRG6 mice along with purified human B cells (Supplemental Methods). (D) Representative flow plots of plasmablast frequency in the spleen at 2 weeks after injection, as quantified in E. One-way ANOVA with Dunn’s multiple correction. (F) Human IgG levels detected by ELISA in mice from E. Wilcoxon’s matched-pairs signed-rank test. (G) Bar graph shows expansion of ICOS+CD4+ T cells after CCB therapy in patients with no HG-irAEs and those with HG-irAEs. Wilcoxon’s matched-pairs rank test. (H) B cells were cultured with flow-sorted ICOS+CD4+ and ICOS–CD4+ T cells from patients with HG-irAEs or no HG-irAEs. Bar graph shows fold change in plasmablasts in ICOS+ versus ICOS– cocultures. Mann-Whitney. (I) FlowSOM performed on ICOS+CD4+ T cells obtained following 1 cycle of combination therapy identified 10 metaclusters (MCs). Bar graph shows proportions of these MCs in patients with HG-irAEs or no HG-irAEs. Mann-Whitney. (J) Depletion of Tregs in patients with no HG-irAEs leads to enhanced B cell activation by ICOS+CD4+ T cells. Purified B cells were cultured with ICOS–, bulk ICOS+, or Treg-depleted ICOS+CD4+ T cells from patients with no HG-irAEs. Dot plot shows plasmablast frequency as percentage of B cells. Bar graph shows data for 7 different experiments. Wilcoxon’s matched-pairs rank test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts